Cargando…

Molecular Mechanism of Action of RORγt Agonists and Inverse Agonists: Insights from Molecular Dynamics Simulation

As an attractive drug-target, retinoic acid receptor-related orphan receptor-gamma-t (RORγt) has been employed widely to develop clinically relevant small molecular modulators as potent therapy for autoimmune disease and cancer, but its molecular mechanism of action (MOA) remains unclear. In the pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Nannan, Yuan, Congmin, Ma, Xiaojun, Wang, Yonghui, Gu, Xianfeng, Fu, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321388/ https://www.ncbi.nlm.nih.gov/pubmed/30513894 http://dx.doi.org/10.3390/molecules23123181

Ejemplares similares

Elucidation of an Allosteric Mode of Action for a Thienopyrazole RORγt Inverse Agonist
por: de Vries, Rens M. J. M., et al.
Publicado: (2020)

Digoxin, an Overlooked Agonist of RORγ/RORγT
por: Karaś, Kaja, et al.
Publicado: (2019)

Molecular dynamics of the ERRγ ligand-binding domain bound with agonist and inverse agonist
por: Sasidharan, Santanu, et al.
Publicado: (2023)

Discovery of a Novel Class of Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders
por: Fiorillo, Bianca, et al.
Publicado: (2023)

Ligand-Based Design of Allosteric Retinoic Acid Receptor-Related Orphan Receptor γt (RORγt) Inverse Agonists
por: Meijer, Femke A., et al.
Publicado: (2019)

Correction to “Discovery of a Novel Class of Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders”
por: Fiorillo, Bianca, et al.
Publicado: (2023)

Identification of the Natural Steroid Sapogenin Diosgenin as a Direct Dual-Specific RORα/γ Inverse Agonist
por: Schwarz, Patrik F., et al.
Publicado: (2022)

Synthetic RORγ agonists regulate multiple pathways to enhance antitumor immunity
por: Hu, Xiao, et al.
Publicado: (2016)

HDX-MS reveals structural determinants for RORγ hyperactivation by synthetic agonists
por: Strutzenberg, Timothy S, et al.
Publicado: (2019)

Identification of Selective ERRγ Inverse Agonists
por: Kim, Jina, et al.
Publicado: (2016)

Therapeutic Effect of a Synthetic RORα/γ Agonist in an Animal Model of Autism
por: Wang, Yongjun, et al.
Publicado: (2015)

Correction: HDX-MS reveals structural determinants for RORγ hyperactivation by synthetic agonists
por: Strutzenberg, Timothy S, et al.
Publicado: (2019)

Insights into the molecular mechanism of positive cooperativity between partial agonist MK-8666 and full allosteric agonist AP8 of hGPR40 by Gaussian accelerated molecular dynamics (GaMD) simulations
por: An, Xiaoli, et al.
Publicado: (2021)

RORα and RORγ expression inversely correlates with human melanoma progression
por: Brożyna, Anna A., et al.
Publicado: (2016)

Novel synthetic RORγ agonist compounds as a potential anti-tumor therapeutic approach
por: Hu, Xiao, et al.
Publicado: (2014)

The molecular mechanisms of action of PPAR-γ agonists in the treatment of corneal alkali burns (Review)
por: Zhou, Hongyan, et al.
Publicado: (2016)

Molecular Dynamics Simulations Based on 1-Phenyl-4-Benzoyl-1-Hydro-Triazole ERRα Inverse Agonists
por: Gao, Zhipei, et al.
Publicado: (2021)

RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers
por: Xia, Li, et al.
Publicado: (2022)

Structural change of retinoic-acid receptor-related orphan receptor induced by binding of inverse-agonist: Molecular dynamics and ab initio molecular orbital simulations
por: Suzuki, Shusuke, et al.
Publicado: (2020)

Regulation of p53 Stability and Apoptosis by a ROR Agonist
por: Wang, Yongjun, et al.
Publicado: (2012)

Simulations of Biased Agonists in the β(2) Adrenergic Receptor with Accelerated Molecular Dynamics
por: Tikhonova, Irina G., et al.
Publicado: (2013)

Conformation Transition of Intracellular Part of Glucagon Receptor in Complex With Agonist Glucagon by Conventional and Accelerated Molecular Dynamics Simulations
por: Bai, Qifeng, et al.
Publicado: (2019)

Molecular Recognition of Agonist and Antagonist for Peroxisome Proliferator-Activated Receptor-α Studied by Molecular Dynamics Simulations
por: Liu, Mengyuan, et al.
Publicado: (2014)

Understanding the Action of RARγ Agonists on Human Osteochondroma Explants
por: Garcia, Sonia A., et al.
Publicado: (2020)

Synthesis of A-9758, an Inverse Agonist of Retinoic Acid-Related Orphan Receptor γt
por: Marvin, Christopher C., et al.
Publicado: (2022)

Insights into the actions of angiotensin-1 receptor (AT1R) inverse agonists: Perspectives and implications in COVID-19 treatment
por: Heimfarth, Luana, et al.
Publicado: (2021)

Elucidation of Inverse Agonist Activity of Bilastine
por: Mizuguchi, Hiroyuki, et al.
Publicado: (2020)

New Insights into the PPARγ Agonists for the Treatment of Diabetic Nephropathy
por: Jia, Zhanjun, et al.
Publicado: (2014)

Molecular mechanisms underlying mifepristone's agonistic action on ovarian cancer progression
por: Ponikwicka-Tyszko, Donata, et al.
Publicado: (2019)

Statistics for the analysis of molecular dynamics simulations: providing P values for agonist-dependent GPCR activation
por: Bruzzese, Agustín, et al.
Publicado: (2020)

Probing the Activation Mechanisms of Agonist DPI-287 to Delta-Opioid Receptor and Novel Agonists Using Ensemble-Based Virtual Screening with Molecular Dynamics Simulations
por: Dean, Emily, et al.
Publicado: (2023)

Antitumor action of the peroxisome proliferator-activated receptor-γ agonist rosiglitazone in hepatocellular carcinoma
por: BO, QI-FU, et al.
Publicado: (2015)

Elucidation of Agonist and Antagonist Dynamic Binding Patterns in ER-α by Integration of Molecular Docking, Molecular Dynamics Simulations and Quantum Mechanical Calculations
por: Sakkiah, Sugunadevi, et al.
Publicado: (2021)

PPARγ in Complex with an Antagonist and Inverse Agonist: a Tumble and Trap Mechanism of the Activation Helix
por: Frkic, Rebecca L., et al.
Publicado: (2018)

Biochemical and structural basis for the pharmacological inhibition of nuclear hormone receptor PPARγ by inverse agonists
por: Irwin, Sean, et al.
Publicado: (2022)

Recent Molecular Insights into Agonist-specific Binding to the Mu-Opioid Receptor
por: Zádor, Ferenc, et al.
Publicado: (2022)

Inverse Agonistic Action of 3-Iodothyronamine at the Human Trace Amine-Associated Receptor 5
por: Dinter, Juliane, et al.
Publicado: (2015)

Molecular Mode of Action of TRAIL Receptor Agonists—Common Principles and Their Translational Exploitation
por: Wajant, Harald
Publicado: (2019)

Molecular dynamics simulations reveal the selectivity mechanism of structurally similar agonists to TLR7 and TLR8
por: Wang, Xiaoyu, et al.
Publicado: (2022)

Discovery of novel RARα agonists using pharmacophore-based virtual screening, molecular docking, and molecular dynamics simulation studies
por: Ghorayshian, Atefeh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j54gjn88fb3pfc3ba3plvjtppv